Trial Profile
The study to examine the appropriate skin dose in intensity modulated radiotherapy with cetuximab
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 May 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 14 May 2021 Status changed from recruiting to completed.
- 13 Nov 2015 New trial record